ロード中...
FGFR1 is an adverse outcome indicator for luminal A breast cancers
Fibroblast growth factor receptor 1 (FGFR1) has been suggested to be the candidate gene for 8p11–12 amplification in breast cancer and its therapeutic/prognostic value is explored. Most previous studies focused on FGFR1 gene amplification, which may not necessarily lead to protein expression. Theref...
保存先:
| 出版年: | Oncotarget |
|---|---|
| 主要な著者: | , , , , , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
Impact Journals LLC
2015
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4826266/ https://ncbi.nlm.nih.gov/pubmed/26673008 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.18632/oncotarget.6563 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|